
|Articles|November 1, 2001
FDA working to speed up alerts
Recognizing the slow process by which the FDA alerts companies to recallprescription drugs and other products, the agency is working to streamlineits procedures.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Tinlarebant NDA submission completed for Stargardt disease type 1, targeting first approved therapy
2
FDA accepts Outlook Therapeutics' resubmitted BLA for ONS-5010 (LYTENAVA)
3
Recognizing biomarkers of Alzheimer Disease using OCTA
4
Midyear cataract check-in: What 2026 has brought to the OR and beyond
5





















